Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model

Journal of Vascular Surgery

Volumn 49, Issue 3, 2009, Pages 719-727

  Dai, Jianping ^a   Louedec, Liliane ^a   Philippe, Monique ^a   Michel, Jean Baptiste ^a   Houard, Xavier ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; DODECYL SULFATE SODIUM; FIBRINOGEN RECEPTOR; GELATINASE B; TICAGRELOR;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA; ARTERY DIAMETER; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL RAT; GUINEA PIG; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ADENOSINE; ADENOSINE DIPHOSPHATE; ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELASTIC TISSUE; GUINEA PIGS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RATS; RATS, INBRED LEW; RECEPTORS, PURINERGIC P2; THROMBOSIS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 61349183737     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.09.057     Document Type: Article

References (40)

1. Fontaine V., Touat Z., Mtairag el M., Vranckx R., Louedec L., Houard X., et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 164 (2004) 2077-2087
2. Yamazumi K., Ojiro M., Okumura H., and Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 175 (1998) 297-301
3. Adolph R., Vorp D.A., Steed D.L., Webster M.W., Kameneva M.V., and Watkins S.C. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 25 (1997) 916-926
4. Kazi M., Thyberg J., Religa P., Roy J., Eriksson P., Hedin U., et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 38 (2003) 1283-1292
5. Touat Z., Ollivier V., Dai J., Huisse M.G., Bezeaud A., Sebbag U., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168 (2006) 1022-1030
6. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161 (2002) 1701-1710
7. Sarda-Mantel L., Coutard M., Rouzet F., Raguin O., Vrigneaud J.M., Hervatin F., et al. 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 (2006) 2153-2159
8. van Giezen J.J., and Humphries R.G. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. Semin Thromb Hemost 31 (2005) 195-204
9. Cattaneo M. P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents. Eur Heart J 27 (2006) 1010-1012
10. Leon C., Alex M., Klocke A., Morgenstern E., Moosbauer C., Eckly A., et al. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103 (2004) 594-600
11. Klinkhardt U., Graff J., and Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther 71 (2002) 176-185
12. Klinkhardt U., Bauersachs R., Adams J., Graff J., Lindhoff-Last E., and Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73 (2003) 232-241
13. Allaire E., Mandet C., Bruneval P., Bensenane S., Becquemin J.P., and Michel J.B. Cell and extracellular matrix rejection in arterial concordant and discordant xenografts in the rat. Transplantation 62 (1996) 794-803
14. Allaire E., Bruneval P., Mandet C., Becquemin J.P., and Michel J.B. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 122 (1997) 73-81
15. Allaire E., Muscatelli-Groux B., Guinault A.M., Pages C., Goussard A., Mandet C., et al. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg 239 (2004) 417-427
16. Allaire E., Guettier C., Bruneval P., Plissonnier D., and Michel J.B. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 19 (1994) 446-456
17. Eckly A., Gendrault J.L., Hechler B., Cazenave J.P., and Gachet C. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation. Thromb Haemost 85 (2001) 694-701
18. Wolf Y.G., Thomas W.S., Brennan F.J., Goff W.G., Sise M.J., and Bernstein E.F. Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms. J Vasc Surg 20 (1994) 529-535
19. Satta J., Laara E., and Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. J Vasc Surg 23 (1996) 737-739
20. Furie B., and Furie B.C. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10 (2004) 171-178
21. Lindholt J.S., Sorensen H.T., Michel J.B., Thomsen H.F., and Henneberg E.W. Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovasc Surg 42 (2008) 329-334
22. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
23. Caplice N.M., Bunch T.J., Stalboerger P.G., Wang S., Simper D., Miller D.V., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A 100 (2003) 4754-4759
24. Allaire E., Forough R., Clowes M., Starcher B., and Clowes A.W. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102 (1998) 1413-1420
25. Allaire E., Muscatelli-Groux B., Mandet C., Guinault A.M., Bruneval P., Desgranges P., et al. Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg 36 (2002) 1018-1026
26. Dai J., Losy F., Guinault A.M., Pages C., Anegon I., Desgranges P., et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Cirulation 112 (2005) 1008-1015
27. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., and Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110 (2002) 625-632
28. de Gaetano G., Cerletti C., and Evangelista V. Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis 29 (1999) 41-49
29. Hayashi S., Watanabe N., Nakazawa K., Suzuki J., Tsushima K., Tamatani T., et al. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation 102 (2000) 1710-1717
30. Wright S.D., Weitz J.I., Huang A.J., Levin S.M., Silverstein S.C., and Loike J.D. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A 85 (1988) 7734-7738
31. Boyle J.R., McDermott E., Crowther M., Wills A.D., Bell P.R., and Thompson M.M. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 27 (1998) 354-361
32. Eliason J.L., Hannawa K.K., Ailawadi G., Sinha I., Ford J.W., Deogracias M.P., et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112 (2005) 232-240
33. Hannawa K.K., Eliason J.L., Woodrum D.T., Pearce C.G., Roelofs K.J., Grigoryants V., et al. L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 112 (2005) 241-247
34. Folkesson M., Kazi M., Zhu C., Silveira A., Hemdahl A.L., Hamsten A., et al. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost 98 (2007) 427-433
35. Michel J.B., Thaunat O., Houard X., Meilhac O., Caligiuri G., and Nicoletti A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler Thromb Vasc Biol 27 (2007) 1259-1268
36. Anidjar S., Dobrin P.B., Chejfec G., and Michel J.B. Experimental study of determinants of aneurysmal expansion of the abdominal aorta. Ann Vasc Surg 8 (1994) 127-136
37. Wang L., Jacobsen S.E., Bengtsson A., and Erlinge D. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5 (2004) 16
38. Shanker G., Kontos J.L., Eckman D.M., Wesley-Farrington D., and Sane D.C. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis 22 (2006) 213-220
39. Inoue K., Hosoi J., and Denda M. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 127 (2007) 362-371
40. Hechler B., Vigne P., Leon C., Breittmayer J.P., Gachet C., and Frelin C. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol 53 (1998) 727-733